Clinical Trial Update: Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCD [Phase 2]

View source ↗

Summary

Phase 2 randomized trial comparing intranasal ketamine with intranasal midazolam in individuals with obsessive-compulsive disorder; the study was terminated and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Intranasal ketamine (ketamine)
• intranasal Midazolam (midazolam)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Obsessive-Compulsive Disorder | Phase 2 | Status: TERMINATED | Results posted: 2017-02-23